Possible contribution of ß-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Works matching IS 01676997 AND DT 2010 AND VI 28 AND IP 3
Results: 23
1
2
Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Ongoing DNA synthesis in the rat cerebral cortex is regulated by a proteolytic pathway independent of the proteasome and calpains.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 242, doi. 10.1007/s10637-009-9238-4
- By:
- Publication type:
- Article
5
Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 205, doi. 10.1007/s10637-009-9235-7
- By:
- Publication type:
- Article
6
Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 251, doi. 10.1007/s10637-009-9241-9
- By:
- Publication type:
- Article
7
Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 284, doi. 10.1007/s10637-009-9253-5
- By:
- Publication type:
- Article
8
Synthesis and in vitro characterization of ionone-based chalcones as novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 291, doi. 10.1007/s10637-009-9251-7
- By:
- Publication type:
- Article
9
Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 299, doi. 10.1007/s10637-009-9254-4
- By:
- Publication type:
- Article
10
Acute left ventricular dysfunction induced by a panHER and VEGFR tyrosine kinase inhibitor in a phase I trial.
- Published in:
- 2010
- By:
- Publication type:
- Report
11
Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 334, doi. 10.1007/s10637-009-9257-1
- By:
- Publication type:
- Article
12
Possible contribution of β-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 306, doi. 10.1007/s10637-009-9248-2
- By:
- Publication type:
- Article
13
MMPT: a thiazolidin compound inhibits the growth of lung cancer H1792 cells via Fas-mediated and caspase-dependent apoptosis pathway.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 318, doi. 10.1007/s10637-009-9259-z
- By:
- Publication type:
- Article
14
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 326, doi. 10.1007/s10637-009-9316-7
- By:
- Publication type:
- Article
15
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
16
Safety and efficacy of panitumumab following cetuximab: retrospective review of the Memorial Sloan-Kettering experience.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 353, doi. 10.1007/s10637-009-9268-y
- By:
- Publication type:
- Article
17
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD).
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 260, doi. 10.1007/s10637-009-9243-7
- By:
- Publication type:
- Article
18
Screening of a PKC ζ-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 268, doi. 10.1007/s10637-009-9242-8
- By:
- Publication type:
- Article
19
The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 276, doi. 10.1007/s10637-009-9245-5
- By:
- Publication type:
- Article
20
Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 216, doi. 10.1007/s10637-009-9240-x
- By:
- Publication type:
- Article
21
FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 234, doi. 10.1007/s10637-009-9232-x
- By:
- Publication type:
- Article
22
Silibinin ameliorates oxidative stress induced aberrant crypt foci and lipid peroxidation in 1, 2 dimethylhydrazine induced rat colon cancer.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 225, doi. 10.1007/s10637-009-9237-5
- By:
- Publication type:
- Article
23
Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 343, doi. 10.1007/s10637-009-9265-1
- By:
- Publication type:
- Article